Scholars Central

Conference abstractPublished 2021

Generating real world evidence for regulators: the past, the present and the future

Authors: Massoud Toussi

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This keynote session will be divided into three sections: In the first part, a review of post authorization safety studies (PASS) from EU-PAS Register will be conducted. The characteristics of PASS in terms of the objectives (investigation of safety concerns, study of drug utilization, assessment of risk minimization measures, etc), the design (longitudinal, cross sectional), the data sources (primary, secondary), and the endpoints will be presented and compared between PASS registered from 2012 to 2015 and those conducted from 2015 to 2020. In a second part, an unpublished study of the interactions with the Pharmacovigilance Risk Assessment Committee (PRAC) over the protocol of 12 studies measuring risk minimization measures (RMMs) will be presented and the strategies for interacting with PRAC will be discussed. In the last part, the trends and perspectives for future of PASS will be presented and brief insights about these perspectives will be provided ot the audience. These include more involvement of different stakeholders, especially patients, in defining research questions, more systematic use of secondary data and data landscaping, increased integration of automation and common data models in evidence generation, and enhanced transparency requirements.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in International Journal of Drug Development and Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Drug Development and Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Massoud Toussi”